Autonomix Medical, Inc. (AMIX) vs Artelo Biosciences, Inc. (ARTL)
A side-by-side comparison of Autonomix Medical, Inc. and Artelo Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMIX
Autonomix Medical, Inc.
$3.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ARTL
Artelo Biosciences, Inc.
$3.51HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AMIX vs ARTL
growth of $100 · dividends reinvested · last 3yAMIX -99.8% (-88.2%/yr)ARTL -95.4% (-64.2%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
AMIX ARTL
AMIX vs ARTL: by the numbers
- •AMIX is the larger company ($2M vs $1M market cap).
Metrics side by side
Valuation
| Metric | AMIX | ARTL |
|---|---|---|
| P/B ratio | 0.61 | 0.27 |
Profitability
| Metric | AMIX | ARTL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -509.36% | -253.57% |
| ROIC | -518.15% | -219.36% |
Growth (annualized)
| Metric | AMIX | ARTL |
|---|---|---|
| Total return CAGR (5Y) | N/A | -64.27% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.